Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Brain Neoplasms × pembrolizumab × Clear all

Status

Recruiting 10 Completed 7 Active not recruiting 6 Terminated 3 Withdrawn 2 Unknown 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 22 Melanoma 16 Neoplasms 8 Breast Neoplasms 8 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Renal Cell 5 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Prostatic Neoplasms 3 Lymphoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Hodgkin Disease 3 Glioblastoma 3 Esophageal Neoplasms 3 Carcinoma 3 Neoplasms, Squamous Cell 2 Fallopian Tube Neoplasms 2 Carcinoma, Transitional Cell 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Thyroid Neoplasms 1

Interventions

Radiosurgery 11 Radiotherapy 10 Temozolomide 8 Magnetic Resonance Spectroscopy 6 Erlotinib Hydrochloride 6 Surgical Procedures, Operative 5 Pemetrexed 5 Carboplatin 5 Bevacizumab 5 pyrotinib 4 icotinib 4 aumolertinib 4 Gefitinib 4 Spermine Synthase 3 Radiation 3 Lomustine 3 Etoposide 3 Drug Therapy 3 Dexmedetomidine 3 Chlorotoxin 3 Carmustine 3 osimertinib 2 apatinib 2 Trastuzumab 2 Thiotepa 2 Surveys and Questionnaires 2 Paclitaxel 2 Nivolumab 2 Neuropsychological Tests 2 Metformin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03458455 2023-11-01

TREATMENT

Oslo University Hospital

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡